Hemant Surgical Industries Limited (BOM:543916)
570.00
-29.95 (-4.99%)
At close: Oct 23, 2026
BOM:543916 Revenue
In the fiscal year ending March 31, 2026, Hemant Surgical Industries had annual revenue of 2.32B INR with 117.38% growth. Hemant Surgical Industries had revenue of 1.67B in the half year ending March 31, 2026, with 251.89% growth. That makes Hemant Surgical Industries the 32,636th largest company in the world by revenue and 2,405th in India.
Revenue
2.32B
Revenue Growth
+117.38%
P/S Ratio
3.57
Revenue / Employee
21.27M
Employees
109
Market Cap
8.29B
Revenue by Geography
- India 2.21B 95.7%
- Exports 98.76M 4.3%
Fiscal year ended Mar 31, 2026 See the full BOM:543916 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.32B | 1.25B | 117.38% |
| Mar 31, 2025 | 1.07B | 10.30M | 0.97% |
| Mar 31, 2024 | 1.06B | -35.41M | -3.24% |
| Mar 31, 2023 | 1.09B | 55.78M | 5.39% |
| Mar 31, 2022 | 1.04B | 438.05M | 73.30% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| RSWM Limited | 45.54B |
| Vadilal Enterprises | 14.04B |
| Ambika Cotton Mills | 8.47B |
| Indosolar | 5.15B |
| Sunshield Chemicals | 4.55B |
| Themis Medicare | 3.32B |
| Aptus Pharma | 811.18M |
| SJ Corporation | 739.82M |